A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Discover how tirzepatide, a diabetes drug, offers hope for congenital generalized lipodystrophy (CGL) treatment, potentially ...

(NEJM Evidence) A KFF analysis showed that over one in four Medicare beneficiaries with overweight or obesity -- representing ... to use with compatible insulin pumps as part of an automated ...

However, studies suggest that almost half of all people using automatic insulin pumps fail to achieve this," explains Dr ...

"Pump shutdown will cause insulin delivery to suspend ... Instead of using insulin, a person's body will begin to break down fat for energy. This releases ketones in the body, which can cause ...

The study is thought to be the first to estimate the prevalence of obesity among Americans with ... can no longer produce adequate levels of insulin on their own, and must instead rely on an insulin ...

Skeletal muscle fat infiltration (IMAT) is linked to coronary microvascular dysfunction and increased cardiovascular risk, ...